Aurobindo Pharma reports a strong Q2 performance, with net profit rising by about a third and revenue increasing by roughly a quarter. Across the reports, the company’s Q2 net profit is reported at around ₹1,124 crore, reflecting gains in both bottom-line earnings and operating income.
The coverage also notes that revenue grows 24% year-on-year, with Business Line and Times of India highlighting the net profit increase and describing revenue growth as “record” for operations. NDTV adds more shareholder-focused detail, stating that a dividend will be provided and giving a specific timeframe.
Overall, the outlets largely agree on the headline profit and revenue trends for the quarter. Differences lie mainly in how much emphasis is placed on shareholder returns versus operational growth, as well as the exact presentation of the dividend schedule and revenue figures.
